TARO Taro Pharmaceutical Industries Ltd

Taro Pharmaceutical Industries Ltd is a science-based pharmaceutical company. It develops, manufacture and market Rx and OTC (over-the-counter) pharmaceutical products primarily in the United States, Canada and Israel.

$34.23  -0.28 (-0.81%)
As of 08/12/2022 16:00:02 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—Specialty &
Index country:  Israel
Country of incorporation:  Israel
IPO date:  02/11/2013
Outstanding shares:  37,584,631
Average volume:  19,585
Market cap:   $1,286,521,919
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
Sedol:      2872423
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   0.00
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy